|
|
Volumn 141, Issue 1, 2001, Pages 164-172
|
|
Highlights from the XXII Congress of the European Society of Cardiology: August 26 to 30, 2000
a a a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
C REACTIVE PROTEIN;
CARVEDILOL;
EPTIFIBATIDE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LEFRADAFIBAN;
PLACEBO;
TETRAHYDROLIPSTATIN;
TROPONIN T;
WARFARIN;
ABLATION THERAPY;
ACUTE CORONARY SYNDROME;
ACUTE HEART INFARCTION;
ANTICOAGULANT THERAPY;
ARTERY REOCCLUSION;
CARDIOLOGY;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CONFERENCE PAPER;
CONGENITAL HEART DISEASE;
CORONARY ARTERY OCCLUSION;
DRUG EFFICACY;
FIBRINOLYTIC THERAPY;
FOLLOW UP;
HEART FAILURE;
HEART MUSCLE NECROSIS;
HEART MUSCLE REVASCULARIZATION;
HEART OUTFLOW TRACT OBSTRUCTION;
HOSPITAL MORTALITY;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY;
INTENSIVE CARE;
ISCHEMIC HEART DISEASE;
MEDICAL SOCIETY;
MULTICENTER STUDY (TOPIC);
NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;
OBESITY;
OUTPATIENT;
PERCUTANEOUS CORONARY INTERVENTION;
PHASE 2 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN BLOOD LEVEL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
ST SEGMENT DEPRESSION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
RANDOMIZED CONTROLLED TRIAL;
CARDIOLOGY;
CARDIOVASCULAR DISEASES;
HUMANS;
|
|
EID: 0035219792
PISSN: 00028703
EISSN: 10976744
Source Type: Journal
DOI: 10.1067/mhj.2001.111923 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|